Sonoma Pharmaceuticals, Inc.
SNOA· Nasdaq
Filed Jun 30, 2014 · 10-K · 91 days after period end · 0001019687-14-002591
derived · Computed from the longer spans the company filed.
| Metric | Q4 2014dderived from reported figures | Q4 2010dderived from reported figures |
|---|---|---|
| Revenue | $2.91M | $2.71M |
| Net Income | $7.46M | -$1.69M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sonoma Pharmaceuticals, Inc. · CIK 1367083 · Engraved from SEC EDGAR
ended Mar 31, 2014 · filed Jun 30, 2014 · 91 d after period end